Anthera Pharmaceuticals Inc (ANTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -99,073 | -66,179 | -41,736 | -18,566 | -40,414 |
| Depreciation Amortization | 902 | 596 | 348 | 97 | 888 |
| Accounts payable and accrued liabilities | 13,574 | 13,618 | 5,925 | 2,566 | 2,664 |
| Other Working Capital | 18,951 | 16,610 | 11,281 | 8,027 | 3,577 |
| Other Operating Activity | -7,421 | -11,749 | -4,580 | -1,978 | 5,507 |
| Operating Cash Flow | $-73,067 | $-47,104 | $-28,762 | $-9,854 | $-27,778 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 21,578 | 19,572 | 19,323 | 11,322 | -23,338 |
| PPE Investments | -1,346 | -1,318 | -1,318 | N/A | -22 |
| Investing Cash Flow | $20,232 | $18,254 | $18,005 | $11,322 | $-23,360 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 24,700 | 24,700 | 24,700 | 24,709 | -210 |
| Common Stock Issued | 54,608 | 54,525 | 54,175 | 36 | 87,740 |
| Other Financing Activity | -879 | -879 | -25 | 0 | 0 |
| Financing Cash Flow | $78,429 | $78,346 | $78,850 | $24,745 | $87,530 |
| Exchange Rate Effect | N/A | N/A | 0 | 315 | -165 |
| Beginning Cash Position | 40,030 | 40,030 | 40,030 | 40,030 | 3,803 |
| End Cash Position | 65,624 | 89,526 | 108,123 | 66,558 | 40,030 |
| Net Cash Flow | $25,594 | $49,496 | $68,093 | $26,528 | $36,227 |
| Free Cash Flow | |||||
| Operating Cash Flow | -73,067 | -47,104 | -28,762 | -9,854 | -27,778 |
| Capital Expenditure | -1,346 | -1,318 | -1,318 | 0 | -22 |
| Free Cash Flow | -74,413 | -48,422 | -30,080 | -9,854 | -27,800 |